FDA inspection
Galephar Pharmaceutical Research Inc.: FDA inspection ending Oct 18, 2024
FDA inspection 1252181 · Voluntary Action Indicated (VAI) · Juncos, PR
Key facts
| Inspection ID | 1252181 |
|---|---|
| Firm | Galephar Pharmaceutical Research Inc. |
| FEI number | 3003068480 |
| Address | Road #198 Ste 100 Km 14.7 |
| City | Juncos |
| State | PR |
| ZIP | 00777 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Oct 18, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data